One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Technical parameter
■ Drive square with turboworm or belt drive options
■ Base aluminum alloy once formed, easy to install
■ Streamlined design, beautiful and generous
■ Good reversibility, can move the door body at will during operation, not easy to damage
■ Dual-machine linkage or interlock, set to synchronous or asynchronous mode
■ Adjustable closing force and pressing force
■ Can connect magnetic lock, electric lock
■ High reliability, low power consumption remote control
■ Fault code indication
Product characteristics
■ Flat door] electromechanical automatic control system, DC motor drive, with spring [] and i] type optional, built-in microprocessor control unit, with self-diagnosis and continuous inspection of all states of the door function. Can be installed on the 1] lintel _, can also be installed on the door, can be opened from the inside or outside, the drive arm scissors arm or chute type, anodized aluminum coated plastic housing, open or close anti-extrusion safety device, when encountered obstacles, not only can make [the door immediately reverse, but also remember the affected point, at low speed to approach this point, Only when the confirmed obstacle has been removed, it can be restored to the standard operating state. The function selector is integrated in the motor, and the parameters are clear and easy to adjust.
■ Maximum width of door body: 1,400mm i] Body weight: 120kg Power 220V (+6%-10%) 50(60) Hz power 100W.
Audited Supplier
Pharma Sources Insight January 2025
